Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995)

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 617-624

  Mulders, Mick N ^a   Reimerink, Johan H J ^a   Koopmans, Marion P G ^a   Van Loon, Anton M ^a   Van Der Avoort, Harrie G A M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RIVER WATER;

ARTICLE; CLINICAL ARTICLE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; INFECTION RISK; NETHERLANDS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VIRUS ISOLATION;

EID: 0030854580     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514081     Document Type: Article

References (27)

1. World Health Assembly. Global eradication of poliomyelitis by the year 2000. Resolution WHA41.28. Geneva: World Health Organization, 1988.
2. Wright PF, Kim-Farley RJ, de Quadros CA, et al. Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 1991;325:1774-9.
3. Hull HF, Ward NA, Hull BP, Milstien JB, de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994;343:1331-7.
4. Ward NA, Kim-Farley RJ, Milstien JB, Hull HF, Torel C, de Quadros C. Poliomyelitis eradication. The expanded programme on immunization of the world health organization. In: Kurstak E, ed. Control of virus disease. 2nd ed. New York: Marcel Dekker, 1993:247-66.
5. Rümke HC, PM Oostvogel, G van Steenis, AM van Loon. Poliomyelitis in The Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992. Epidemiol Infect 1995;115:289-98.
6. Bijkerk H. Poliomyelitis in The Netherlands. Dev Biol Stand 1981;47:223-40.
7. Bijkerk H. Surveillance and control of poliomyelitis in The Netherlands. Rev Infect Dis 1984;6(suppl):S451-6.
8. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM. Geographic distribution of wild poliovirus type 1 genotypes. Virology 1987;160:311-22.
9. Oostvogel PM, van Wijngaarden JK, van der Avoort HGAM, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet 1994;344:665-70.
10. Mulders MM, Reimerink JHJ, Ras A, et al. Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993). J Clin Microbiol 1995;33:3252-6.
11. Schaap, GJP, H Bijkerk, RA Coutinho, JG Kapsenberg, AL van Wezel. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol 1984;29:124-40.
12. van Olphen M, Kapsenberg JG, van de Baan E, Kroon WA. Removal of enteric viruses from surface water at eight waterworks in The Netherlands. Appl Environ Microbiol 1984;47:927-32.
13. Drebot MA, Mulders MN, Campbell JJ, Kew OM, Lee SHS. The molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993. Appl Environ Microbiol 1997;63:519-23.
14. Reichler MR, Abbas A, Kharabsheh S, et al. Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. J Infect Dis 1997;175(suppl 1):S62-70.
15. Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA. Molecular epidemiology of polioviruses. Semin Virol 1995;6:401-14.
16. op de Coul AAW, Peeters MF. A patient with a severe paralytic form of poliomyelitis after a stay in Tunesia (in Dutch) [letter]. Neth J Med 1982;23:1054-5.
17. World Health Organization. Manual for the virological investigation of poliomyelitis. (WHO/EPI/CDS/POLIO/90.1). Geneva: WHO, 1992.
18. van Wezel AL, Hazendonk AG. Intratypic differentiation of poliomyelitis virus strains by specific antisera. Intervirology 1979;2:2-8.
19. Osterhaus ADME, van Wezel AL, Hazendonk AG, Uytdehaag FCGM, van Asten JAAM, van Steenis G. Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera. Intervirology 1983;20:129-36.
20. De L, Nottay B., Yang CF, Holloway BP, Pallansch MA, Kew OM. Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J Clin Microbiol 1995;33:562-71.
21. van der Avoort HGAM, Hull BP, Hovi T. A comparative study of five methods for the intratypic differentiation of polioviruses. J Clin Microbiol 1995;33:2562-6.
22. Mulders MN, Lipskaya GY, van der Avoort HGAM, Koopmans MPG, Kew OM, van Loon AM. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis 1995;171:1399-405.
23. Nei M. Distance matrix methods. In: Molecular evolutionary genetics. New York, NY: Columbia University Press, 1987:293-8.
24. Huovilainen A, Kinnunen L, Pöyry T, Laaksonen L, Roivainen M, Hovi T. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins. Virology 1994;199:228-32.
25. Nottay BK, Kew OM, Hatch MH, Heyward JT, Obijeski JF. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 1981;108:405-23.
26. van der Avoort HGAM, Reimerink JHJ, Ras A, Mulders MN, van Loon AM. Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in The Netherlands. Epidemiol Infect 1995;114:481-91.
27. Pöyry T, Kinnunen L, Kapsenberg J, Kew O, Hovi T. Type 3 poliovirus/ Finland/1984 is genetically related to common Mediterranean strains. J Gen Virol 1990;71:2535-41.